Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Novartis discovers deltaF508 mutant CFTR correctors

Aug. 28, 2020

Mereo BioPharma initiates phase Ib/II study of alvelestat in COVID-19 respiratory disease

Aug. 26, 2020

Trevena initiates proof-of-concept study of TRV-027 in patients with COVID-19

Aug. 26, 2020

Hubei Bio-Pharmaceutical, Humanwell Healthcare patent E-NPP 2 inhibitors

Aug. 25, 2020

Tocilizumab may prevent risk of invasive mechanical ventilation or death in severe COVID-19

Aug. 25, 2020

European Commission approves Kaftrio with ivacaftor for cystic fibrosis

Aug. 24, 2020

Preclinical pilot study data presented for NX-P004 programme in IPF

Aug. 24, 2020

Oxygen therapy harms lungs via lung, gut microbiome

Aug. 19, 2020

Interim analysis data from ODYSSEY study of tradipitant in COVID-19 pneumonia

Aug. 18, 2020

Improved oxygenation observed in COVID-19 patients treated with icatibant

Aug. 18, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...